Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)
China
· Delayed Price · Currency is CNY 5.88
-0.02 (-0.34%)
Apr 30, 2025, 3:04 PM CST
SHE:300039 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 374.91 | 327.87 | 190.8 | 140.11 | 106.12 | Upgrade
|
| Depreciation & Amortization | 36.05 | 34.97 | 31.71 | 33.86 | 40.81 | Upgrade
|
| Other Amortization | 0.29 | 2.68 | 0.01 | - | 0.21 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.26 | 0.21 | 0.17 | 0.22 | 0.07 | Upgrade
|
| Asset Writedown & Restructuring Costs | -0.28 | 7.33 | 0.65 | -6.16 | -1.05 | Upgrade
|
| Loss (Gain) From Sale of Investments | -13.98 | -4.92 | 10.69 | 4.85 | 1.65 | Upgrade
|
| Other Operating Activities | -4.28 | -1.64 | -0.44 | -0.68 | 1.21 | Upgrade
|
| Change in Accounts Receivable | -0.14 | 99.53 | 58.32 | -74.9 | 137.88 | Upgrade
|
| Change in Inventory | -16.26 | -10.33 | 4.06 | 27.22 | -2.23 | Upgrade
|
| Change in Accounts Payable | -102.8 | -60.18 | 76.9 | -4.37 | -25.24 | Upgrade
|
| Change in Other Net Operating Assets | - | -5.33 | 6.8 | 3.33 | -2.18 | Upgrade
|
| Operating Cash Flow | 278.95 | 382.66 | 376.42 | 126.08 | 250.65 | Upgrade
|
| Operating Cash Flow Growth | -27.10% | 1.66% | 198.56% | -49.70% | -24.97% | Upgrade
|
| Capital Expenditures | -140.52 | -29.08 | -31.62 | -42.55 | -13.94 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.03 | 0.03 | 0.27 | 0.15 | 0.11 | Upgrade
|
| Cash Acquisitions | - | - | - | -14.52 | -4.45 | Upgrade
|
| Investment in Securities | -31.26 | -181.21 | -257.11 | -29.93 | 69.34 | Upgrade
|
| Other Investing Activities | 138.32 | 11.63 | 3.08 | 3.34 | 14.3 | Upgrade
|
| Investing Cash Flow | -33.43 | -198.63 | -285.37 | -83.51 | 65.21 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 35.72 | Upgrade
|
| Long-Term Debt Issued | 2.99 | - | - | - | - | Upgrade
|
| Total Debt Issued | 2.99 | - | - | - | 35.72 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -37.72 | - | Upgrade
|
| Total Debt Repaid | - | - | - | -37.72 | - | Upgrade
|
| Net Debt Issued (Repaid) | 2.99 | - | - | -37.72 | 35.72 | Upgrade
|
| Common Dividends Paid | -104.64 | -62.76 | -52.3 | -31.64 | -104.6 | Upgrade
|
| Other Financing Activities | 2.42 | - | - | - | -0.52 | Upgrade
|
| Financing Cash Flow | -99.23 | -62.76 | -52.3 | -69.37 | -69.39 | Upgrade
|
| Net Cash Flow | 146.3 | 121.27 | 38.75 | -26.8 | 246.47 | Upgrade
|
| Free Cash Flow | 138.43 | 353.59 | 344.8 | 83.53 | 236.71 | Upgrade
|
| Free Cash Flow Growth | -60.85% | 2.55% | 312.79% | -64.71% | -25.71% | Upgrade
|
| Free Cash Flow Margin | 9.40% | 22.18% | 30.82% | 7.59% | 26.07% | Upgrade
|
| Free Cash Flow Per Share | 0.13 | 0.34 | 0.33 | 0.08 | 0.23 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 0.52 | Upgrade
|
| Cash Income Tax Paid | 239.25 | 255.43 | 144.47 | 157.16 | 151.53 | Upgrade
|
| Levered Free Cash Flow | -900.67 | 261.78 | 275.04 | 16.78 | 191.45 | Upgrade
|
| Unlevered Free Cash Flow | -900.67 | 261.78 | 275.04 | 16.88 | 191.78 | Upgrade
|
| Change in Net Working Capital | 1,027 | -59.62 | -161.5 | 49.03 | -114.69 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.